Clarity Pharmaceuticals Ltd:年度股東大會通告/代表委任表格
Clarity Pharmaceuticals Ltd:清潔通知
Clarity Pharmaceuticals Ltd:證券報價申請-CU6
Clarity Pharmaceuticals Ltd:Copper-67 SAR-bispsma 最新動態
Clarity Pharmaceuticals Ltd:美國食品藥品管理局對三期試驗的積極指導
Clarity Pharmaceuticals Ltd:米歇爾·帕克晉升爲首席執行官
Clarity Pharmaceuticals Ltd:Cu-64 SAR-bispsma 的臨床生產協議
Clarity Pharmaceuticals Ltd:董事權益變更公告-At Cb CR TR MP
Clarity Pharmaceuticals Ltd:清潔通知
Clarity Pharmaceuticals Ltd:證券報價申請-CU6
Clarity Pharmaceuticals Ltd:COBRA 研究被選爲最受好評的口頭報告
Clarity Pharmaceuticals Ltd:公司治理聲明
Clarity Pharmaceuticals Ltd:附錄 4G
Clarity Pharmaceuticals Ltd:向股東提交的年度報告
Clarity Pharmaceuticals Ltd:不再是主要持有人
Clarity Pharmaceuticals Ltd:關於未上市證券的通知-CU6
Clarity Pharmaceuticals Ltd:年度股東大會日期
Clarity Pharmaceuticals Ltd:董事的初步利息通知-Parker
Clarity Pharmaceuticals Ltd:任命執行董事爲Clarity董事會成員
Clarity Pharmaceuticals Ltd:成爲重要的持有者
暫無數據
暫無數據